Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before starting any supplement regimen or making changes to your health routine. The information presented here is based on published research but should not replace professional medical guidance.
Of all the compounds I’ve researched over the past 25 years, fisetin is one of a small handful that genuinely excites me — not because of marketing hype, but because the underlying science is both rigorous and, frankly, remarkable.
Fisetin is a naturally occurring flavonoid found in strawberries, apples, and a handful of other foods. What makes it extraordinary is that it belongs to a class of compounds called senolytics — substances that selectively destroy senescent cells, the so-called “zombie cells” that accumulate with age and are now understood to drive much of what we experience as ageing.
In this guide, I’ll walk you through the science behind fisetin, what the human research actually shows, how to get it from food, and whether supplementation is worth considering.
What Is Fisetin?
Fisetin (3,3′,4′,7-tetrahydroxyflavone) is a polyphenolic flavonoid belonging to the flavonol subclass. It occurs naturally in many fruits and vegetables — strawberries being the richest dietary source — and has been studied for its antioxidant, anti-inflammatory, and neuroprotective properties for over two decades.
But it’s fisetin’s senolytic activity that has catapulted it to the front of longevity research. In a landmark 2018 study from the Buck Institute for Research on Aging and Mayo Clinic, researchers screened 10 flavonoids for senolytic potency and found fisetin to be by far the most effective — reducing the burden of senescent cells in tissues far more powerfully than any of the others tested.[1]
What Are Senescent Cells?
Senescent cells are cells that have stopped dividing but haven’t died. Instead of clearing themselves through apoptosis, they linger in tissues, secreting a toxic cocktail of inflammatory signals known as the SASP (senescence-associated secretory phenotype). This chronic low-grade inflammation — sometimes called “inflammaging” — is now linked to virtually every major age-related disease, from cardiovascular disease and neurodegeneration to sarcopenia and cancer.
How Fisetin Works: Senolytics Explained
Fisetin targets senescent cells through several interacting mechanisms. Understanding these helps explain both why it works and why the dosing protocol for fisetin is unusual compared to most supplements.
Inhibition of Pro-Survival Pathways in Senescent Cells
Normal healthy cells that have suffered DNA damage will either repair themselves or undergo apoptosis (programmed cell death). Senescent cells exploit pro-survival signalling networks — particularly the PI3K/AKT/mTOR pathway and BCL-2 family anti-apoptotic proteins — to resist this death signal.
Fisetin disrupts these pro-survival pathways selectively in senescent cells. By inhibiting BCL-2 and BCL-XL proteins and suppressing the AKT pathway, fisetin effectively re-sensitises senescent cells to apoptosis — allowing the body to clear them as it normally would in youth.[1]
Suppression of the SASP
Even before full senolysis occurs, fisetin acts as a senomorphic — it reduces the secretory output of senescent cells. By inhibiting NF-κB and mTOR signalling (both key drivers of SASP expression), fisetin dampens the inflammatory cascade that senescent cells produce. This means less tissue damage and systemic inflammation even from cells that haven’t yet been eliminated.[2]
Antioxidant & Neuroprotective Effects
Fisetin also acts as a direct antioxidant, scavenging reactive oxygen species (ROS) and upregulating the body’s own antioxidant defences via the Nrf2 pathway. This is separate from its senolytic activity and likely contributes to the cognitive protection observed in animal studies.
The Pulsed Dosing Rationale
Unlike most supplements taken daily, many researchers and clinicians studying senolytics use a “pulsed” protocol — a high dose taken for 2–3 consecutive days once per month. The rationale is that senolytics don’t need to be present continuously; they clear senescent cells in short bursts, after which the body needs time to process the cleared debris. This approach may also reduce the risk of accumulating supra-physiological flavonoid concentrations over time.
What the Research Actually Shows
I want to be straightforward here: the most compelling fisetin research remains in animal models. The human clinical data, while promising, is still early-stage. Here’s an honest summary of what we know.
The Yousefzadeh 2018 Study (Landmark)
This is the paper that put fisetin on the longevity map. Researchers at the Buck Institute and Mayo Clinic tested 10 flavonoids across multiple cell lines and tissue types, measuring their ability to reduce p21 (a senescence marker) and clear senescent cells.[1]
Fisetin was the clear winner. In old mice (equivalent to ~75 years in human terms), fisetin treatment:
- Reduced senescent cell burden significantly across multiple tissues
- Extended median remaining lifespan by approximately 10%
- Improved tissue function, including better grip strength and coordination
- Reduced markers of inflammation across multiple organ systems
Importantly, the mice were already old when treatment began — suggesting fisetin may be effective even when started late in life.
Human Clinical Trials: The Current Evidence
Translating mouse data to humans is never straightforward, and fisetin is no exception. The first human trials of fisetin as a senolytic were launched by Mayo Clinic’s Robert and Arlene Kogod Center on Aging.
A pilot clinical trial published in 2021 (NCT02848131) examined the pharmacokinetics and safety of high-dose fisetin (20mg/kg/day for 2 consecutive days) in older adults with frailty. The study confirmed that fisetin is safe and well-tolerated at high doses in humans, and provided preliminary evidence of reduced senescent cell markers in adipose tissue.[3]
Larger randomised controlled trials are underway at the time of writing — including in Alzheimer’s disease (where senescent cell burden is implicated in neuroinflammation) and chronic kidney disease. We don’t yet have definitive RCT data on longevity outcomes in humans, and I think it’s important to be honest about that.
My Assessment
The animal data for fisetin is among the most compelling in all of longevity research — the effect sizes are large and the mechanism is well understood. The human safety data is reassuring. What we’re waiting for are larger, powered trials measuring meaningful outcomes (not just biomarkers). For a healthy adult with no contraindications, the risk profile looks favourable given what we know. But this isn’t a guaranteed anti-ageing intervention — it’s a promising one that warrants watching closely.
Food Sources of Fisetin
Fisetin occurs naturally in a range of fruits and vegetables, though concentrations vary considerably. Strawberries are by far the richest source.
| Food | Fisetin Content (approx.) | Notes |
|---|---|---|
| Strawberries | 160 µg/g fresh weight | Highest dietary source by a significant margin |
| Apples | 26 µg/g | Concentrated in the skin; peeling removes most fisetin |
| Persimmons | 250 µg/g | Excellent source when in season |
| Lotus root | ~170 µg/g | Common in Asian cuisine |
| Onions | 4.8 µg/g | Lower concentration but widely consumed |
| Grapes | 3.9 µg/g | Minor contributor |
| Kiwi | 2.0 µg/g | Minor contributor |
A note on dietary adequacy: even if you eat strawberries daily, you’re unlikely to reach the doses used in senolytic research through diet alone. A typical therapeutic pulsed dose in human studies is 500–1,500mg — the equivalent of several kilograms of strawberries eaten over two consecutive days. Food sources contribute to overall flavonoid intake and health, but supplementation is the only practical route if you’re targeting senolytic activity.
Fisetin Dosage Guide
Fisetin dosing in research follows two distinct protocols, and the appropriate one depends on your goal. Please consult your GP before starting any high-dose supplementation regimen — the information below is for educational purposes and reflects what’s been used in studies, not a personalised medical recommendation.
Daily Low-Dose Protocol
Some people take fisetin daily at 100–200mg as a general antioxidant and neuroprotective supplement. This is closer to what you might achieve with a fisetin-rich diet and is generally associated with its antioxidant and anti-inflammatory properties rather than senolysis.
Pulsed High-Dose Senolytic Protocol
The protocol emerging from Mayo Clinic and other research groups is a higher dose taken for 2–3 consecutive days, once per month:
- Typical range used in studies: 500–1,500mg per day for 2 days
- Weight-adjusted dose used in human trial: 20mg/kg body weight/day × 2 days
- Frequency: Once monthly, with some protocols suggesting quarterly
Taking fisetin with a fat-containing meal significantly improves absorption — fisetin is fat-soluble and bioavailability is notably higher with food.
Bioavailability Considerations
Fisetin has notoriously poor bioavailability when taken in standard capsule form — it’s rapidly metabolised and has limited water solubility. Several supplement manufacturers have developed enhanced delivery forms (liposomal, phytosome/complexed with phospholipids) that claim significantly improved absorption. The research on these forms is still emerging, but the mechanism is sound. If you’re taking standard fisetin powder/capsules, always take with a meal containing healthy fats.
Best Fisetin Supplements (2026)
When choosing a fisetin supplement, I look for: verified fisetin content (not just “plant extract”), clear mg dosing, and ideally third-party testing. Liposomal or phytosome forms offer better bioavailability but cost more.
Disclosure: Some links below are affiliate links. If you purchase through them, I may earn a small commission at no extra cost to you. I only recommend products I’ve researched and believe offer genuine value.
What to Look For
- Standardised fisetin content: Look for supplements specifying mg of actual fisetin, not just the weight of the plant extract
- Third-party tested: For a supplement at these doses, independent testing (NSF, Informed Sport, or equivalent) is important
- Enhanced bioavailability: Liposomal or Fisetin-SR (sustained release) forms may offer better absorption
- Reputable longevity brands: DoNotAge, ProHealth Longevity, and Life Extension all offer well-regarded fisetin products
I’ll be updating this section with specific product reviews as I test and evaluate more options throughout 2026. See my full guide to anti-aging supplements for context on where fisetin fits within a broader longevity supplement stack.
Side Effects & Safety
Fisetin has a reassuring safety profile based on available data, both from long-term animal studies and the human pharmacokinetic trials conducted to date.
Generally Reported Side Effects
- GI discomfort: The most common complaint at high doses — nausea, loose stools, or abdominal discomfort. Usually transient and resolves after the pulsed dose period.
- Headache: Reported occasionally in higher-dose protocols; typically mild.
- Fatigue: A small number of people report temporary fatigue during the 2-day pulsed protocol — possibly related to the inflammatory clearance process.
Drug Interactions to Be Aware Of
Fisetin inhibits certain CYP450 liver enzymes, which metabolise many medications. This is particularly relevant if you take:
- Blood thinners (warfarin, direct oral anticoagulants)
- Immunosuppressants (cyclosporin, tacrolimus)
- Statins metabolised by CYP3A4
- Chemotherapy agents
If you’re on any prescription medication, discuss fisetin with your GP or pharmacist before starting — particularly for the high-dose pulsed protocol.
Who Should Avoid Fisetin
- Pregnant or breastfeeding women (insufficient safety data)
- Anyone on warfarin or other anticoagulants (without medical supervision)
- People with known sensitivity to flavonoids or strawberry allergy
Frequently Asked Questions
What does fisetin do for the body?
Fisetin acts as a senolytic — it selectively targets and eliminates senescent (“zombie”) cells that accumulate with age and drive chronic inflammation. It also acts as a senomorphic, reducing the inflammatory SASP output of senescent cells. Additionally, fisetin has antioxidant, anti-inflammatory, and neuroprotective properties that are distinct from its senolytic activity.
How much fisetin should I take per day?
There is no established RDA for fisetin. Research protocols vary: daily low-dose use typically ranges from 100–200mg; senolytic pulsed protocols used in clinical studies range from 500–1,500mg per day for 2 consecutive days, once monthly. Always take with a fat-containing meal for better absorption, and consult your GP before starting a high-dose protocol.
Is fisetin better than quercetin as a senolytic?
Based on the Yousefzadeh 2018 screening study, fisetin showed significantly stronger senolytic activity than quercetin when tested head-to-head across multiple cell lines. Quercetin (often combined with dasatinib in research) has more clinical trial data at this point, but fisetin’s potency profile is notably superior. Some longevity researchers use both in rotation.
Can I get enough fisetin from strawberries?
Not if you’re targeting senolytic activity. Strawberries contain approximately 160µg of fisetin per gram — to reach even 500mg from diet alone would require eating around 3kg of strawberries on consecutive days. Strawberries are an excellent health food and will contribute to your overall flavonoid intake, but supplementation is the only practical way to reach therapeutic-range doses.
Does fisetin extend human lifespan?
We don’t yet know. Fisetin extended median lifespan in old mice by approximately 10% in the landmark 2018 study. Human trials are underway but currently measure biomarkers (senescent cell burden, inflammatory markers) rather than longevity endpoints — those trials would take decades. The mechanistic case is strong; the clinical proof in humans remains incomplete.
Citations
- Yousefzadeh MJ, Zhu Y, McGowan SJ, et al. Fisetin is a senotherapeutic that extends health and lifespan. EBioMedicine. 2018;36:18-28. PMID: 30279143
- Kirkland JL, Tchkonia T. Senolytic drugs: from discovery to translation. J Intern Med. 2020;288(5):518-536. PMID: 32686219
- Mahoney SA, Venkatasubramanian R, Darby TM, et al. Intermittent supplementation with fisetin improves arterial function in old mice by decreasing cellular senescence. Aging Cell. 2024;23(1):e14000. PMID: 37771072
- Zhu Y, Tchkonia T, Pirtskhalava T, et al. The Achilles’ heel of senescent cells: from transcriptome to senolytic drugs. Aging Cell. 2015;14(4):644-658. PMID: 25754370
- López-Otín C, Blasco MA, Partridge L, Serrano M, Kroemer G. Hallmarks of aging: An expanding universe. Cell. 2023;186(2):243-278. PMID: 36599349
- Tchkonia T, Zhu Y, van Deursen J, Campisi J, Kirkland JL. Cellular senescence and the senescent secretory phenotype: therapeutic opportunities. J Clin Invest. 2013;123(3):966-972. PMID: 23454759
Last reviewed: 14 Apr 2026 by Steve Butler, Health Writer & Longevity Researcher